← All status records
Educational regulatory-status record
Wegovy (semaglutide) finished product
FDA-approvedregulatory categoryFDA-approved finished product record
This page explains an official classification boundary. It is not a recommendation, suitability assessment, or commercial listing.
Official status explanation
The cited FDA prescribing-information record identifies Wegovy as a finished product with FDA-approved labeling. This page applies that status to the identified product record, not to every semaglutide product or use.
Record freshness: within the review interval · last reviewed 2026-08-18 · review due 2026-09-17
What this record does not conclude
- It does not establish that an unbranded, compounded, or otherwise different product has the same status.
- It does not determine whether a product or treatment is appropriate for a particular person.
- It does not replace the complete official label or professional medical advice.
Source and review trail
- Source
- WEGOVY (semaglutide) prescribing information
- Source type
- FDA
- Source date
- 2026-05
- Checked
- 2026-08-18
- Review rule
- Human review required within 30 days and after material official change.
There are no vendors, purchase links, product destinations, or personalized selection tools on this educational page.